Dr. Christopher L. Marsh, MD

Dr. Marsh practices at Scripps Green Hospital in La Jolla, California, part of Scripps Health.

Dr. Marsh's NPI, 1023098043, was assigned on January 17, 2006. Dr. Marsh graduated from Loma Linda University School Of Medicine in 1980. Dr. Marsh holds California license A45454.

Dr. Marsh's primary practice is Scripps Green Hospital, at 10666 North Torrey Pines Road, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 554-3600.

Dr. Marsh's primary practice is Scripps Green Hospital in La Jolla, California, part of Scripps Health. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Marsh to 1 more breast imaging center and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marsh practices, 3 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Marsh's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. Marsh is board certified in urology by the American Board of Urology. Dmand AI has Dr. Marsh's licenses on file in 6 states: California, Hawaii, Ohio, Pennsylvania, Washington and Minnesota.

Dmand AI lists kidney transplant and urinary endoscopy among the conditions Dr. Marsh treats.

CMS data shows 113 Medicare services from Dr. Marsh across 3 procedure codes in 2024, for 76 Medicare patients. Medicare paid $14,764 for them. Every service was in an office.

CMS counts 76 Medicare patients who saw Dr. Marsh in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 6.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marsh's median patient age at 55, with 49% women.

In 2024, Dr. Marsh wrote 59 Medicare Part D claims. 63% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $45,879 in total drug cost. In 2023, CMS named 115 claims across 7 drugs.

Dr. Marsh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marsh as offering telehealth.

Dmand AI links 67 papers to Dr. Marsh, published from 2009 to 2024. 2017 was the busiest year, with 6. The most frequent topics are Kidney Transplantation, Graft Rejection and Graft Survival. Dr. Marsh has published most often in Am J Transplant. Dr. Marsh's most frequent co-authors are Mark D. Stegall, MD, Adel Bozorgzadeh, MD and Stanley Jordan, MD.

Dmand AI links Dr. Marsh to 3 clinical trials. TransMedics sponsors the most, 3.

CMS Open Payments shows 90 general payments to Dr. Marsh from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Gilead Sciences, Inc. paid the most, $1,136. It also lists 2 research payments totaling $1,159 in 2019.

Dr. Marsh graduated from Loma Linda University School Of Medicine in 1980.

Dr. Marsh is in network with 9 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.